Wednesday 20 August 2014
 
»
Tag
 
»
AstraZeneca

Pfizer ends $118bn AstraZeneca takeover fight

Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker. The decision ends a month-long public f

More…

AstraZeneca rejects Pfizer's new $118bn offer

Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, casting serious doubt on the US drugmaker's plan for a merger to create the world's biggest pharmaceuticals group. The rebuf

More…

AstraZeneca rejects Pfizer's $106bn bid

US drugmaker Pfizer increased its offer for AstraZeneca to 63 billion pounds ($106 billion) on Friday, but the British company promptly rejected the proposal, which would create the world's biggest pharmaceuticals company. Ast

More…

Pfizer offers record $106bn for AstraZeneca

US drugmaker Pfizer has raised its offer for AstraZeneca to 63 billion pounds ($106 billion), a deal that would create the world's biggest pharmaceuticals company. Pfizer's pursuit of AstraZeneca, which would boost the Ame

More…

Pfizer offers record $106bn for AstraZeneca

US drugmaker Pfizer has raised its offer for AstraZeneca to 63 billion pounds ($106 billion), a deal that would create the world's biggest pharmaceuticals company. Pfizer's pursuit of AstraZeneca, which would boost the Ame

More…

Pfizer chasing AstraZeneca in $100bn-plus deal

US drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene. Pfizer confirmed on Monday it made a bid approa

More…

Pfizer chasing AstraZeneca in $100bn-plus deal

US drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene. Pfizer confirmed on Monday it made a bid approa

More…

Astra eyes $4.1bn Bristol diabetes venture stake

AstraZeneca has agreed to buy Bristol-Myers Squibb's stake in the companies' diabetes joint venture for up to $4.1 billion in a deal that will help return the group to growth, sending its shares to an new high. AstraZeneca

More…

AstraZeneca buys biotech firm for $440m

British drugmaker AstraZeneca said on Tuesday its MedImmune unit would buy biotech company Spirogen for up to $440 million to bolster its research and development pipeline in oncology.   Privately held Spirogen f

More…

Sanofi strong in emerging markets as rivals flag

French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads